Primary Health Properties PLC
18 February 2004
18th February 2004
Primary Health Properties PLC
Primary Health Properties PLC ("PHP") announces that its wholly owned subsidiary
Primary Health Investment Properties Limited has purchased a recently completed
purpose built medical centre in Naoroji Street, London WC1 for approximately
£4.4 million (net assets acquired £4.4 million) with a rent roll of some
£280,000 per annum. The medical centre forms part of a larger development
incorporating commercial accommodation, luxury residential flats and a school,
developed by Thornsett Homes Limited. Primary Health Investment Properties
Limited has also entered into an option to purchase the freehold of the property
for around £175,000 once certain conditions have been met. Approximately
£11,000 p.a. of ground rent will then be payable to Primary Health Investment
Properties Limited.
Further details:
Harry Hyman Adam Dalgliesh
Managing Director Property Director
Primary Health Properties PLC Primary Health Properties PLC
Tel: 01483 306912 Tel: 01483 306912
Mobile: 07973 344768 Mobile: 07976 753168
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.